Cite Filings / CTKB / 0001104659-23-101999

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

Cytek Biosciences, Inc. Filed 2023-09-19 Acc 0001104659-23-101999

Documents 1

SC 13D/A Beneficial Ownership Report , tm2326419d1_sc13da.htm

Around this filing

2023-09-26 4 Chief Financial Officer sold 3,000 shares at $6.38 ($19,140)
2023-09-20 4 Chief Technology Officer sold 20,000 shares at $6.49 ($129,800)
2023-09-19 SC 13D/A Beneficial Ownership Report
2022-03-14 SC 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2326419d1_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…